Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Nuvelo enrolls patients in phase III trial of 10 mg alfimeprase for CO

Aug. 28, 2007

YM-150 effective and safe as venous thromboembolism prophylaxis

Aug. 23, 2007

Daiichi Sankyo selects DT-831j as clinical candidate for thrombosis

Aug. 22, 2007

Polyphenolic grape extract activity may explain cardiovascular benefits of red wine

Aug. 16, 2007

Bayer describes new thrombin inhibitors

Aug. 16, 2007

The Medicines Company files sNDA to expand Angiomax label

Aug. 13, 2007

LEO Pharma enrolls first patient in phase II study of ATryn in DIC indication

Aug. 9, 2007

Biovitrum and Wyeth to copromote BeneFIX in Nordic countries

Aug. 9, 2007

Omrix submits appplication to the EMEA for marketing approval of Evicel

July 31, 2007

Development of alfimeprase resumes for blood clot-related disorders

July 27, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...